DENTSPLY SIRONA Inc. - Income Statement (TTM)

DENTSPLY SIRONA Inc.
AT ˙ WBAG ˙ US24906P1093
€ 14,32 ↑0.31 (2.25%)
2025-07-10
SHARE PRICE
Income Statement (TTM)

DENTSPLY SIRONA Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 3,371 3,339 3,491 4,062 4,207 4,231 4,174 4,135 4,042 3,922 3,931 3,936 3,936 3,965 3,940 3,896 3,900 3,793 3,719 3,671
Change (%) -0.96 4.55 16.36 3.57 0.57 -1.35 -0.93 -2.25 -2.97 0.23 0.13 0.00 0.74 -0.63 -1.12 0.10 -2.74 -1.95 -1.29
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,641 1,639 1,682 1,832 1,886 1,887 1,886 1,863 1,828 1,795 1,802 1,838 1,851 1,875 1,867 1,861 1,865 1,825 1,791 1,765
Change (%) -0.13 2.62 8.92 2.95 0.05 -0.05 -1.22 -1.88 -1.81 0.39 2.00 0.71 1.30 -0.43 -0.32 0.21 -2.14 -1.86 -1.45
% of Revenue 48.68 49.09 48.18 45.10 44.83 44.60 45.18 45.05 45.23 45.77 45.84 46.70 47.03 47.29 47.39 47.77 47.82 48.11 48.16 48.08
Gross Operating Profit 1,730 1,700 1,809 2,230 2,321 2,344 2,288 2,272 2,214 2,127 2,129 2,098 2,085 2,090 2,073 2,035 2,035 1,968 1,928 1,906
Change (%) -1.75 6.41 23.27 4.08 0.99 -2.39 -0.70 -2.55 -3.93 0.09 -1.46 -0.62 0.24 -0.81 -1.83 0.00 -3.29 -2.03 -1.14
% of Revenue 51.32 50.91 51.82 54.90 55.17 55.40 54.82 54.95 54.77 54.23 54.16 53.30 52.97 52.71 52.61 52.23 52.18 51.89 51.84 51.92
SG&A 1,275 1,309 1,323 1,458 1,535 1,547 1,536 1,552 1,564 1,596 1,638 1,641 1,612 1,617 1,611 1,596 1,612 1,581 1,526 1,469
Change (%) 2.65 1.07 10.20 5.28 0.78 -0.71 1.04 0.77 2.05 2.63 0.18 -1.77 0.31 -0.37 -0.93 1.00 -1.92 -3.48 -3.74
% of Revenue 37.83 39.20 37.90 35.89 36.49 36.56 36.80 37.53 38.69 40.69 41.67 41.69 40.96 40.78 40.89 40.97 41.33 41.68 41.03 40.02
R&D 210 123 129 154 166 171 176 178 180 174 175 179 184 184 180 172 166 165 159 155
Change (%) -41.43 4.88 19.38 7.79 3.01 2.92 1.14 1.12 -3.33 0.57 2.29 2.79 0.00 -2.17 -4.44 -3.49 -0.60 -3.64 -2.52
% of Revenue 6.23 3.68 3.70 3.79 3.95 4.04 4.22 4.30 4.45 4.44 4.45 4.55 4.67 4.64 4.57 4.41 4.26 4.35 4.28 4.22
OpEx 3,131 3,071 3,132 3,444 3,587 3,605 3,598 3,593 3,572 3,565 3,615 3,658 3,647 3,676 3,658 3,629 3,643 3,571 3,476 3,389
Change (%) -1.93 1.99 9.96 4.15 0.50 -0.19 -0.14 -0.58 -0.20 1.40 1.19 -0.30 0.80 -0.49 -0.79 0.39 -1.98 -2.66 -2.50
% of Revenue 92.88 91.97 89.72 84.79 85.26 85.20 86.20 86.89 88.37 90.90 91.96 92.94 92.66 92.71 92.84 93.15 93.41 94.15 93.47 92.32
Operating Income 240 268 359 618 620 626 576 542 470 357 316 278 289 289 282 267 257 222 243 282
Change (%) 11.67 33.96 72.14 0.32 0.97 -7.99 -5.90 -13.28 -24.04 -11.48 -12.03 3.96 0.00 -2.42 -5.32 -3.75 -13.62 9.46 16.05
% of Revenue 7.12 8.03 10.28 15.21 14.74 14.80 13.80 13.11 11.63 9.10 8.04 7.06 7.34 7.29 7.16 6.85 6.59 5.85 6.53 7.68
Interest Expense -39 -46 -71 -61 -57 -64 -36 -51 -53 -76 -83 -96 -96 -97 -95 -93 -89 -89 -90 -94
Change (%) 17.95 54.35 -14.08 -6.56 12.28 -43.75 41.67 3.92 43.40 9.21 15.66 -0.00 1.04 -2.06 -2.11 -4.30 -0.00 1.12 4.44
% of Revenue -1.16 -1.38 -2.03 -1.50 -1.35 -1.51 -0.86 -1.23 -1.31 -1.94 -2.11 -2.44 -2.44 -2.45 -2.41 -2.39 -2.28 -2.35 -2.42 -2.56
Net Income -80 -73 179 370 401 411 368 345 -816 -950 -1,038 -1,025 -214 -132 -95 -185 -413 -910 -908 -949
Change (%) -8.29 -345.21 106.70 8.38 2.49 -10.46 -6.25 -336.52 16.42 9.26 -1.25 -79.12 -38.32 -28.03 94.74 123.24 120.34 -0.22 4.52
% of Revenue -2.36 -2.19 5.13 9.11 9.53 9.71 8.82 8.34 -20.19 -24.22 -26.41 -26.04 -5.44 -3.33 -2.41 -4.75 -10.59 -23.99 -24.42 -25.85

Source: Capital IQ

Other Listings
DE:DY2 € 12,22
IT:1XRAY € 12,01
GB:0I8F US$ 14,60
US:XRAY US$ 14,62
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista